Biocryst Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
04.08.23
/
50%
€6.90
Target price
04.08.24
-
Performance (%)
-7.45%
End price
05.08.24
€6.39
Summary
This prediction ended on 05.08.24 with a price of €6.39. With a performance of -7.45%, the BUY prediction by Jefferies_Financial_ finished with a loss. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 2.983% | 2.983% | 10.164% |
| iShares Core DAX® | -3,64 % | -8,78 % | -0,69 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % | 11,95 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % | 23,39 % |
| iShares S&P 500 | -2,39 % | -2,78 % | 7,62 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten